COF vs PMCB · P/E 62, rev $53.43B vs $8.6M cap
Capital One Financial Corporation (COF) versus PharmaCyte Biotech Inc (PMCB) — a side-by-side from cached financials, not a winner call.
Capital One Financial Corporation (COF) is a credit services company listed on NYSE.
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
Latest reported COF revenue for 2025-12-31 was $53.43B. Net income was $2.45B. Revenue was up 36.6% from 2024-12-31 to 2025-12-31. COF currently screens at market cap $125.00B and trailing P/E 61.8.
Latest reported PMCB revenue for 2025-04-30 was $0. Net income was $30.7M. PMCB currently screens at market cap $8.6M.
COF currently screens at market cap $125.00B and trailing P/E 61.8. PMCB currently screens at market cap $8.6M.
Not investment advice. Open the COF and PMCB stock pages for the full models.
Not investment advice.